In spite of increased interest in the interaction of viruses with the cells of the reticuloendothelial system (RES), there exists a paucity of investigations on the function of alveolar macrophages in viral infections with respect either to their role in immunity to viral respiratory diseases or their role as host cells for propagation of virus.
Liu (12) was one of the first investigators to demonstrate viral antigens in alveolar macrophages. He employed fluorescent-antibody techniques to identify the viral antigens present within the cells in nasal smears and sections of lungs obtained from ferrets infected with influenza virus.
In a study on the histopathogenesis of mousepox virus in mice, Roberts (19) observed that alveolar macrophages were among the first cells to contain viral antigens after aerosol infections. He also demonstrated that reticuloendothelial cells of the liver were important in the uptake of viruses present in the vascular compartment.
Gresser (4) was probably the first investigator to report that human white blood cells from venous blood had the capacity to produce interferon. His findings suggested that cells of the RES might contribute to the host's defense mechanisms against viral infections by producing interferon.
Several investigators (1, 6, 7, 10, 17, 22, 23 ) have attempted to define the possible role of interferon in protecting against and in effecting recovery from viral infections. Collectively, their findings suggest that interferon may be an important factor of immunity during the early phases of viral infection before antibody immunity becomes expressed.
The present study was initiated to investigate the possible production of interferon by virusinfected alveolar macrophages as well as the feasibility of passively immunizing macrophages in vitro with alveolar macrophage-produced interferon.
MATERIALS AND METHODS
Animals. New Zealand white rabbits weighing between 1.8 and 2.2 kg were utilized as the source of alveolar macrophages. They were killed by injecting air into the marginal ear veins.
Procurement of alveolar macrophages. Alveolar macrophages were obtained from rabbit lungs by a slight modification of the procedure described by Myrvik, Leake, and Fariss (16) Virus inocula were prepared by freezing and thawing infected cell suspensions three times. The viruscontaining supernatant fluids were stored in 1-ml samples at -70 C.
Virus titrations. Rabbitpox virus was assayed in HEp-2 cell monolayers by a modification of the procedure described by Postlethwaite (18) for plaquing vaccinia virus without an agar overlay. The cells were grown for 24 hr in 60-mm plastic petri dishes (Falcon Plastic Co., Los Angeles, Calif.). The growth medium was removed, and 0.5 ml of inoculum, diluted in Joklik's (9) modification of Puck's saline A (13), was allowed to adsorb for 30 min at 35 to 36 C. A 4-ml amount of a fluid overlay (Medium 199-5% Ca) was added. After 18 to 24 hr of incubation, this medium was replaced with Medium 199 containing 2% heatinactivated calf serum. At 36 to 48 hr after inoculation, the medium was removed and the plates were stained for approximately 30 sec with a 1% aqueous solution of crystal violet, washed with tap water, and dried. The technique of reducing the serum content after 18 to 24 hr of incubation reduced the growth rate of the cells, which maintained the cell sheet as a monolayer. The initial 5% concentration of serum was necessary to obtain optimal plaque development.
Parainfluenza-3 virus was assayed in tubes of HEp-2 cells by a modification of the hemadsorption technique (21) . Half-log dilutions of the virus were made in Hanks' balanced salt solution (BSS), pH 7.4 to 7.6, and 0.2 ml of inoculum was added to each of two or three cell cultures. The virus was allowed to adsorb for 1 hr at 35 to 36 C, after which 1 ml of maintenance medium (Medium 199-5% Ch) was added to each tube. The culture fluids were changed after 24 hr of incubation. At 48 to 72 hr after inoculation, 0.2 ml of 0.4% guinea pig red blood cells in 0.14 M NaCl was added to each tube. The cultures were incubated at 4 C for 30 min, washed with 5 ml of Hanks' BSS, and observed microscopically for hemadsorption and cytopathogenic effect (CPE).
Estimation of viral CPE in alveolar macrophages. Viral cytopathogenic effect in alveolar macrophage preparations was estimated by determining the percentage of the cells which did not exclude trypan blue (14) .
Interferon assay. For virus challenge, extracts of virus-infected and uninfected control fluids, which were to be assayed for the presence of viral inhibitor, were diluted with equal amounts of spinner modified medium. Alveolar macrophages were suspended in the diluted preparations at a cell concentration of 400,000 cells per milliliter. The spinner flasks were incubated at 35 to 36 C for 18 hr in a CO2 incubator. After centrifugation at 200 X g for 10 min, the cell pellets were resuspended in half the original volume of spinner medium. Rabbitpox virus inoculum was added to the cell suspension at a multiplicity of approximately 0.1 plaque-fcrming unit (PFU) per cell, and the cell concentration was adjusted to 400,000 cells per milliliter with additional spinner medium. The viral inoculum was allowed to adsorb for 3 hr in a CO2 incubator. The cell suspension was then centrifuged at 200 X g for 10 min, and the cell pellet was resuspended in spinner medium at the original cell concentration. Samples for viral titrations were removed at desired intervals and stored at -70 C. At each sampling interval, cell counts and the percentage of viable cells were determined. A virus control was incubated for 18 hr in fresh spinner medium rather than interferon or control fluid before inoculation with rabbitpox virus. An uninfected cell control was treated as above except that rabbitpox virus was omitted.
In the assay for plaque reduction, the samples removed at the various intervals were assayed for infectious virus in HEp-2 cell monolayers as described in Materials and Methods. A 75% reduction in the number of plaques in the test system, as compared with the number of plaques in the control system, was considered to be a significant difference. (Table 2) .
RESULTS

Growth of rabbitpox virus
In occasional experiments, the extracts obtained from noninfected control macrophage cultures conferred interferon-like activity on recipient macrophages. These effects were usually slight and showed animal to animal variation. It would not be surprising to find low levels of interferon-like activity in cells obtained from the respiratory tract of rabbits encountering microorganisms in their natural environment. Accordingly, rabbits having a naturally occuring respiratory infection caused by Bordetella bronchiseptica were studied with respect to interferon-like activity associated with their alveolar macrophages. Several experiments of this type failed to reveal the presence of interferon-like activity.
In view of the report that homologous nucleic acid can, under certain conditions, induce interferon activity in cells (20) , it appeared desirable to determine whether or not dead alveolar macrophages or their products could induce interferonlike activity. This possibility warranted special attention, since it was routinely observed that living macrophages removed small numbers of dead cells from the cultures. Experiments were conducted in which suspensions of killed macrophages were added to an equal number of living cells. Incubation was carried out for 24 to 48 hr. No evidence was obtained suggesting that, under the conditions of these experiments, interferonlike activity was induced in living macrophages by dead alveolar macrophages or their breakdown products.
Properties ofthe macrophage interferon. Experiments were performed to determine whether the inhibitor possessed the properties of the prototypic interferon described by Isaacs and Lindenmann (8) . Representative interferon preparations were subjected to the following tests.
Acid stability and dialyzability. Crude interferon prepared in macrophages was dialyzed at 4 C against 100 to 200 volumes of saline, adjusted to pH 4 with 1 N HCI, for 18 to 24 hr, and was (11) lends support to the concept that cells of the RES may be involved in interferon immunity. They observed that tissues containing large numbers of phagocytic ceUs (i.e., spleen) formed interferon more rapidly and in higher titer than did companion tissues with lower populations of phagocytes (i.e., kidney).
Glasgow and Habel (3) found that interferon was produced by peritoneal macrophages following both in vitro and in vivo infection with vaccina virus. They established that passively transferred leukocyte-produced interferon contributed to the attenuation of the course of a vesicular stomatitis virus infection in mice. Glasgow (2), employing an in vitro system, observed that normal mouse peritoneal macrophages inhibited the progression of vaccinia virus infections in mouse embryo fibroblast cultures. He suggested that the protective effect could be due to interferon production by the macrophages as a result of their infection with vaccinia virus.
Isaacs and Hitchcock (7) reported that interferon was produced in the lungs of nonimmune mice infected with a sublethal dose of influenza virus, and postulated that interferon may have promoted recovery from the infection.
The present study establishes that rabbit alveo- 
